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difference in A-V fistula failure was seen for fistulae cannulatedCreation, cannulation and survival of arteriovenous fistulae:
in 15 to 28 days compared with 43 to 84 days.Data from the Dialysis Outcomes and Practice Patterns Study.
Conclusion. Significant differences in clinical practice cur-Background. An arteriovenous (A-V) fistula is the optimal
rently exist between countries regarding the creation of A-Vvascular access for hemodialysis. The National Kidney Founda-
fistulae prior to starting hemodialysis and the timing of initialtion Dialysis Outcomes Quality Initiative (DOQI) recom-
cannulation. Cannulation within 14 days of creation is associatedmends that fistulae should mature for at least one month before
with reduced long-term fistula survival. Fistulae ideally shouldcannulation, but this recommendation is not evidence-based.
be left to mature for at least 14 days before first cannulation.If fistulae are created prior to ESRD and cannulation is possible
earlier without compromising fistula survival, the need for tem-
porary catheters would be reduced.
Methods. Prospective observational data were analyzed for Long-term hemodialysis was made possible initially bya random sample (N  3674) of incident patients at the time
the Quinton-Scribner shunt. Subsequently, the Brescia-of initiating hemodialysis, hemofiltration or hemodiafiltration
Cimino arteriovenous fistula facilitated reliable vascularin 309 facilities in France, Germany, Italy, Japan, Spain, the
United Kingdom, and the United States, taking part in the access. The original report of this arteriovenous (A-V)
Dialysis Outcomes and Practice Patterns Study (DOPPS). fistula in 1966 describes fourteen patients aged between
Results. Although the proportion of patients who had pre- 28 and 54 years with a maximum period of use being 151⁄2dialysis care by a nephrologist differed little between countries,
months [1]. Notably, the fistulae were cannulated the daythere were large variations in the proportion of patients who
after creation. Since 1966, the profile of patients startingcommenced hemodialysis via an A-V fistula, A-V graft or cen-
tral venous catheter. The usual time interval between referral hemodialysis has changed considerably, the majority of
and creation of A-V fistulae also differed greatly between coun- new patients now being more elderly and having greater
tries. For new hemodialysis (HD) patients initiating HD with comorbidity and poorer peripheral circulation. Synthetic
an A-V fistula (N  894) the following results were observed:
vascular grafts have been developed as a further type of(1) median time to first cannulation varied greatly between
permanent A-V access.countries: Japan and Italy (25 and 27 days), Germany (42 days),
If A-V access cannot be created or used, uncuffed andSpain and France (80 and 86 days), UK and US (96 and 98
days). (2) No association was found between cannulation 28 tunneled cuffed catheters in a central vein offer the main
days versus28 days for patient characteristics of age, gender, alternatives for hemodialysis. These have reduced the
and fifteen different classes of patient co-morbid factors. (3) immediate imperative to cannulate A-V fistulae immedi-Risk of A-V fistula failure was increased for incident patients
ately after surgery. It is now common practice for initialwho had a prior temporary access [relative risk (RR)  1.81,
cannulation to be delayed so that the fistula can “ma-P  0.01] or who were female (RR  1.52, P  0.02). (4)
Cannulation14 days after creation was associated with a 2.1- ture,” that is, the vein can become larger in diameter
fold increased risk of subsequent fistula failure (P  0.006) and its wall “arterialize.” The intention of this delay is
compared to fistulae cannulated 14 days. (5) No significant to permit adequate blood flow through the fistula and
to reduce the risk of local hemorrhage at the cannulation
site due to tearing of the vein wall, which may result inKey words: arteriovenous fistula, vascular access, hemodialysis, end-
stage renal disease, cannulation practice, fistula survival, DOPPS. occlusion of the fistula. The current National Kidney
Foundation Dialysis Outcomes Quality Initiative (DOQI)Received for publication March 14, 2002
guidelines endorse this practice and recommend thatand in revised form June 14, 2002
Accepted for publication August 16, 2002 initial cannulation be delayed for at least four weeks
following surgery [2]. However, this guidance is based 2003 by the International Society of Nephrology
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upon opinion and the workgroup was unable to reach a Vascular access data were collected for each patient
at entry into the study and updated whenever a vascularconsensus on the ideal maturation period.
A proportion of patients with end-stage renal disease access-related event occurred. Vascular access informa-
tion included type of access, placement location, andpresents late and requires urgent dialysis [3]. This is
associated with increased morbidity and mortality, some dates of creation, first use and failure. Vascular access-
related infections and procedures also were recorded.of which can be attributed to the temporary access re-
quired [4]. However, the majority of patients are known
Description of patient sample and calculation of A-Vto a nephrologist before dialysis is started. Keeping the
fistula cannulation timetimes between referral for access surgery, fistula creation
and first cannulation to a minimum will substantially Analyses were confined to new hemodialysis (HD)
patients using an A-V fistula at the time of study entry,enhance the possibility that these patients begin hemodi-
alysis with a permanent vascular access. and with the requirement that the study entry date was
within 14 days of the patient’s first-ever HD treatmentThe Dialysis Outcomes and Practice Patterns Study
(DOPPS) is an international prospective observational for ESRD (N  894). Eighty percent of patients in the
analysis entered DOPPS on their date of first-ever dial-study of hemodialysis practice and patient outcomes be-
ing carried out at a random sample of dialysis facilities ysis, and eighty six percent entered DOPPS within two
days of their first-ever dialysis treatment. Therefore, thein North America, Europe, Japan, Australia, and New
Zealand [5]. Data for this article have been taken from study entry date was used as a close approximation for
the date of first A-V fistula use. Time to first A-V fistulaFrance, Germany, Italy, Japan, Spain, the United King-
dom, and the United States. We have compared A-V cannulation was calculated as the time from the A-V
fistula creation date until patient’s study entry date. Thisfistula practice between these countries, identified factors
associated with the time between surgery and initial A-V will slightly overestimate the time to first cannulation in
a small number of patients. Hence, a sensitivity analysisfistula cannulation for new ESRD patients when starting
hemodialysis (HD), and studied the association between was performed using a stricter requirement that the study
entry date had to be within five days of the patient’s first-time to cannulation and subsequent fistula survival.
ever dialysis treatment for ESRD (reducing the study
sample to 588 patients). More than 90% of patients in
METHODS
this sample were on hemodialysis for one day or less
Data sources when entering DOPPS. The A-V fistula survival results
using this stricter study entry date requirement wereData for these analyses were restricted to end-stage
renal disease (ESRD) patients, greater than 17 years of essentially the same as those shown in the Results section
for the less strict study entry date requirement.age, receiving in-center hemodialysis, hemofiltration, or
hemodiafiltration at 145 dialysis facilities in the United
Statistical analysisStates (US), 63 facilities in Japan, 21 facilities in Ger-
many, and 20 facilities each in France, Italy, Spain, and Predictors of “early versus late” first A-V fistula cannu-
lation. Logistic regression was used to investigate thethe United Kingdom (UK). The five European countries
are collectively referred to as Europe (EUR) in this relationship between patient characteristics and whether
A-V fistulae were first cannulated in a short time intervalpaper. Although these five European countries do not
represent all European HD practice, they accounted for (28 days) versus a longer time interval (28 days).
Patient characteristics included as predictor variablesapproximately 84% of all HD patients in the European
Union in 1995 [6]. within the logistic regression analyses (N  694) were:
age, gender, diabetes mellitus, peripheral vascular dis-Data for these analyses were collected from July 1996
to May 2001 in the US, from June 1998 to November ease, diagnosis of dementia or depression, coronary
heart/artery disease, angina, chronic obstructive pulmo-2000 in EUR, and from February 1999 to March 2001 in
Japan. Nationally representative samples were obtained nary disease, pulmonary edema, dyspnea, malnourish-
ment, whether the patient had seen a nephrologist moreusing randomized selection of dialysis facilities and of
their patients with ongoing longitudinal data collection than one month prior to ESRD, A-V fistula placement
in upper versus lower arm, hospitalization within theas described previously [7]. Patient level data were col-
lected from patients’ medical records. Information re- three-month period prior to starting HD, whether the
patient had a prior temporary access, country of resi-garding the typical time from surgery referral to access
placement was obtained from a survey completed by the dence, and facility clustering effects.
Access survival analyses. Cox proportional hazards re-unit’s nurse manager and, if unavailable, survey responses
from the unit’s medical director were used. There was gression was used to model time to first failure of the
A-V fistula as a function of different categories of A-Va strong correlation between these two sources (data not
shown). fistula cannulation time. Time to failure was calculated
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Fig. 1. Proportion of incident patients who
commenced hemodialysis via an arteriove-
nous (A-V) fistula (), A-V graft () and
catheter ( ; either cuffed or uncuffed) in par-
ticipating countries (N  3674). Analysis in-
cluded incident patients who entered DOPPS
within 5 days of their first dialysis treatment.
as the time from first use of the A-V fistula until first variations between countries in the proportion of pa-
tients who commenced hemodialysis via an A-V fistula,failure. Failure was defined as any reported event (such
ranging from 83% in Germany to 48% in the Unitedas thrombosis) resulting in an A-V fistula being non-
Kingdom and only 15% in the United States (Fig. 1).functional for HD, even though the access may be usable
Conversely, a much higher proportion of patients startedat a later time if successfully salvaged by subsequent de-
dialysis via central venous catheters in the United King-clotting or revision procedures. Observations were cen-
dom (50%) and the United States (61%) than in Japansored when a patient departed from the facility or the last
(31%) and other European countries (15 to 39%). Aday of known access follow-up. Models were adjusted for
further 23% of patients in the United States started dial-the following covariates: age, gender, diabetes mellitus,
ysis via an A-V graft, a type of access used rarely inperipheral vascular disease, whether patient had seen
European countries (5%) and Japan (3%).a nephrologist more than one month prior to ESRD,
Since central venous catheters are inevitably requiredwhether A-V fistula was placed in the upper versus lower
when patients present to a nephrologist for the first timearm, and country of residence. This adjustment for coun-
already in need of urgent dialysis, we evaluated the timetry provides for consistency in effects across all countries
interval from first nephrologist visit to ESRD start. Theinstead of allowing a relationship in one country to domi-
proportion of patients who had more than one monthnate the overall results.
of pre-dialysis care by a nephrologist ranged from 72 toAll statistical analyses were performed using SAS ver-
87%, and 65 to 82% saw a nephrologist more than foursion 8. Logistic regression analyses employed the GEN-
months before initiation of dialysis (Fig. 2). The higherMOD procedure with a binomial error distribution and
use of catheters in the UK and US does not appear tologit link function. Facility clustering effects in logistic
be fully explained by this interval since 76% and 68%regression models were accounted for using variance
of UK and US patients, respectively, had seen a nephrol-estimates based on generalized estimating equations
ogist for more than four months (Fig. 2).(GEE) assuming an exchangeable correlation structure
If the time from surgical referral to access creation isand using a “repeated” statement specifying facility-level
particularly long, then patients require a longer periodclustering. Cox regression analyses employed the PHREG
of nephrological care before ESRD in order to startprocedure. Facility clustering effects in these analyses
dialysis using a permanent access. Figure 3 shows thewere addressed using robust standard error estimates
distribution of the time from referral to surgical creationbased on the sandwich estimator [8] with an indepen-
of a permanent A-V access by country as reported bydence working correlation.
the dialysis unit staff. In the UK, staff at the majority of
dialysis facilities (60%) reported intervals of more than
RESULTS four weeks between referral and surgical creation of a
Data on the initially used vascular access from DOPPS permanent access. In contrast, in France, Germany, Italy,
Japan and the United States the majority of units (65 towas based on 3674 HD patients starting ESRD therapy
in EUR, Japan, and the US. These data reveal large 95%) reported little delay (2 weeks) between referral
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Fig. 2. Proportion of patients who had more
than one ( ) or four () months of pre-dial-
ysis care by a nephrologist before the first
dialysis treatment.
Fig. 3. Usual time between referral and sur-
gical creation of a permanent access reported
by dialysis facility nurse managers or medical
directors. Symbols are: () 0 to 2 weeks; ()
2 to 4 weeks; ( ) 4 weeks. Numbers in
brackets denote the number of facilities re-
porting.
and surgery. These variations suggest that there are im- days versus less than 28 days after creation varied be-
tween countries in parallel with the median time to firstportant differences between countries in the clinical
pathway along which patients are prepared for dialysis. cannulation (Fig. 5). For all other countries, these inter-
vals were significantly longer than the intervals for JapanConsidering only those patients who started mainte-
nance HD via an A-V fistula, there is a wide range of or Italy. Prescribed blood flow rates at the time of starting
hemodialysis varied between countries (Table 1), beingintervals between the creation of the fistula and its first
cannulation shown in Figure 4. This interval is less than higher in the US than in Japan or the European coun-
tries. However, a simple regression analysis adjusted forfour weeks in 27% of all patients and more than eight
weeks in 43% of patients. The median time to first fistula facility clustering effects indicated an insignificant rela-
tionship between patient prescribed blood flow rate andcannulation differed between countries, ranging from
28 days in Japan and Italy to 96 and 98 days in the time to first A-V fistula cannulation (P 0.47, N 769).
This relationship remained insignificant after adjustmentUK and US, respectively (Fig. 5). The adjusted odds
ratio of an A-V fistula being cannulated more than 28 for patient age, gender, comorbidity, early nephrologic
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14 days showed separation of the two curves within the
first few days and perhaps further separation after ap-
proximately 200 days (Fig. 7). The relative risk of failure
for fistulae cannulated between 0 and 14 days was in-
creased by a factor of 2.1 compared with those cannulated
after 14 days (P  0.006).
A sensitivity analysis viewing additional categories of
cannulation time suggested that the highest risk period
was during the first 11 days (0 to 11 days RR 2.75, P
0.004, N  57; 12 to 21 days RR  1.16, P  0.73, N 
64, each compared to the reference group of 43 to 84
days). Due to sample size limitations, it was not feasible
to perform fistula survival analysis as a function of differ-
ent categories of cannulation time for patients having aFig. 4. Cumulative distribution of time between the creation of an A-V
fistula and its first cannulation for all incident patients (N  894) and prior temporary access.
for those who had no prior temporary access (86% of total) (number
of patients in each cannulation group indicated in the insert).
DISCUSSION
This international study, using a uniform data collec-
tion instrument, demonstrates large differences betweencare, use of a prior temporary access, and hospitalization
countries in the use of vascular access. Focusing specifi-in the three months prior to study entry (P  0.09, aver-
cally on A-V fistulae, this study shows marked variationsage effect size of a 10 day increase in mean cannulation
between countries in the time interval from patients be-time per 100 mL/min increase in blood flow rate).
ing referred for creation of an A-V fistula to its creation,In the multivariate analysis of factors possibly associ-
and from A-V fistula creation to first cannulation in pa-ated with cannulation of A-V fistulae by day 28 (“early
tients new to maintenance HD.cannulation”), only three factors were statistically sig-
No association was found between initial cannulationnificant (Table 2). Patients who had been seen by a
time and any of the patient characteristics studied. Thisnephrologist more than one month prior to starting dial-
suggests that local circumstances and policies of accessysis had a significantly lower chance of their fistula being
surgery and fistula cannulation are more important thancannulated 28 days after creation. In contrast, patients
patient-related factors in determining cannulation time.who had been hospitalized within three months prior
The blood flow rate prescribed for the first dialysis variedto starting dialysis, and those patients who had a prior
widely between countries (Table 1). This was highest intemporary access, were significantly more likely to have
the US, which had the longest median time betweentheir A-V fistula cannulated 28 days of creation. No
creation and first cannulation.association was found between cannulation 28 days
The percentage of patients presenting to a nephrolo-and patient age, gender and fifteen different classes of
gist within four weeks of starting dialysis showed moder-patient co-morbid factors.
ate differences between the countries included in thisAn analysis of A-V fistula failure indicated a substan-
study. The percentage of patients starting dialysis via atially increased risk of failure in patients who had had a
permanent access, that is, fistula or graft, was highest inprior temporary access [relative risk (RR)  1.81, P 
Germany, which had the lowest percentage of patients0.01] and in female patients (RR compared to males 
referred to a nephrologist at least four weeks prior to1.52, P  0.02). It was found that the hazards for A-V
starting dialysis. However, Germany had the shortestfistula survival were not proportional in patients with or
usual time between referral and access surgery. As re-without a prior temporary access. Therefore, the re-
ported previously [9], there is an association between amaining A-V fistula survival analyses were restricted to
short waiting time for surgery and a high rate of primarypatients without a prior temporary access (N  642).
permanent access use for new ESRD patients.For this group of patients, cannulation within the first
The percentage of patients starting dialysis via a per-14 days after creation was associated with a significantly
manent access is similar between France, Italy, Spainincreased risk of subsequent fistula failure. In this ad-
and Japan. Spain has the highest percentage of patientsjusted analysis, there was no significant trend to decreased
referred to a nephrologist at least four weeks prior tofistula failure among the cannulation intervals greater
ESRD; however, nearly a quarter of Spanish units re-than 14 days (Fig. 6) and fistula failure was not signifi-
cantly different between any of the cannulation interval ported times greater than four weeks between referral
and access surgery. The median cannulation time dif-groups greater than 14 days. A comparison of the survival
of fistulae cannulated within 14 days versus more than fered markedly between these four countries. This sug-
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Fig. 5. Median time to first cannulation of A-V
fistulae by country (bars), and adjusted odds
ratio of an A-V fistula being cannulated 28
days versus28 days after creation relative to
Japan (dashed line within bar). The adjusted
odds ratio for each country except Italy was
significantly different from the adjusted odds
for Japan (P 0.05). Odds ratios are adjusted
for age, gender, peripheral vascular disease, dia-
betes, dementia, depression, malnourishment,
coronary heart disease, coronary artery dis-
ease, angina, pulmonary edema, COPD, dys-
pnea, pre-ESRD care, hospitalization within
3 months of study entry, arm location of A-V
fistula placement, and were limited to A-V
fistulae in which cannulation time was 730
days. All results relate to cannulation of A-V
fistulae used by incident patients when starting
HD; N  694.
Table 1. Median prescribed blood flow rates at the time of starting did not have a permanent access placed during the pre-
hemodialysis using an A-V fistula in Japan, 5 European countries,
ESRD period [9]. This suggests that, in the US, referraland the US
of patients for vascular access creation does not occur
Median blood flow rate early enough during the pre-ESRD period to ensure thatCountry N mL/min
most patients are able to start HD with a permanent
France 134 240
access. High catheter use occurs in the US despite sub-Germany 131 200
Italy 82 265 stantial use of grafts, which often require shorter time
Japan 97 160 periods for maturation compared to A-V fistulae. The
Spain 153 300
higher proportion of US patients using grafts rather thanUK 52 250
US 241 300 native fistulae is dependent upon local practice [10–12].
The finding that the A-V fistula failure rate is greater
in women than men, independent of other risk factors,
has been reported by others [9, 13, 14]. We did not find the
gests that the timing of fistula creation in the predialysis significantly poorer fistula survival in elderly and diabetic
period and subsequent fistula cannulation are coordi- patients as has been reported in single center studies
nated, resulting in a similar percentage of patients start- [13–16], perhaps due to the much wider range of surgical
ing dialysis via a fistula. skill and techniques used in this international study.
Primary permanent access use was lowest in the UK Arteriovenous fistulae that were cannulated within 14
and USA, which had the longest median cannulation days of creation had a significantly increased subsequent
times. In the UK, many units reported long times be- chance of failure. No significant association was found
tween referral and access surgery. In fact, 60% of units between fistula survival and first cannulation after 14 days.
report waiting times greater than four weeks, a percent- In a sensitivity analysis, the highest risk period appeared
age far higher than any other country. This practice would to be within the first 11 days. However, the wide confi-
require UK patients to be referred especially early in dence intervals for the early cannulation categories sug-
the predialysis period in order to increase the likelihood gest that a recommendation to delay cannulation for at
of incident patients starting HD with an A-V fistula. The least 14 days would be prudent.
long periods between creation and cannulation seen in As this is an observational study, it is not possible to
the UK may be a consequence of this and/or a deliberate make a causal link between cannulation and subsequent
policy of long fistula maturation time. fistula failure. Spontaneous fistula thrombosis is also more
In the US, no units reported times greater than four likely early after fistula creation.
weeks between referral and surgery. However, 60% of Only limited data are available with which to compare
patients start HD with a catheter, despite 68% seeing a these results. Culp et al have reported an increased risk
nephrologist for more than four months before ESRD. of thrombosis of A-V fistulae cannulated within 30 days
of creation compared to longer than 30 days [17]. How-Three-fourths of patients who started HD with a catheter
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Fig. 6. Relative risk of A-V fistula failure by
timing of first cannulation. Patients with prior
temporary access excluded. Relative risk ad-
justed for age, gender, diabetes, peripheral
vascular disease, nephrological care prior to
starting dialysis, A-V fistula location in upper
versus lower arm, country, and facility cluster-
ing effects; N  642. Vertical lines indicate
95% confidence intervals.
Table 2. Factors associated with early cannulation of A-V fistulae
(N  694)
AOR of early AV
fistula cannulation
Covariate (28 days vs. 28 days) P value
Seen by nephrologist 1
month prior to ESRD 0.27 0.001
Pulmonary edema 0.60 0.10
AV fistula placed in upper vs.
lower arm 0.67 0.13
Hospitalized within 3 months
prior to starting HD 1.76 0.004
Had a prior temporary access 2.50 0.001
Adjusted odds ratios (AOR) were adjusted for age, gender, diabetes, periph-
eral vascular disease, dementia/depression, coronary heart disease, coronary
artery disease, angina, chronic obstructive pulmonary disease, dyspnea, and mal-
nourishment, which were not significantly related to the outcome variable (P 
Fig. 7. Survival curves for fistulae cannulated either 14 days or 140.05). The model was adjusted also for facility clustering effects and country; 14%
of patients had a prior temporary access but started maintenance hemodialysis via days. Patients with prior temporary access excluded. Relative risk ad-
an A-V fistula. justed for age, gender, diabetes, peripheral vascular disease, nephrologi-
cal care prior to starting dialysis, A-V fistula location in upper versus
lower arm, country, and facility clustering effects. Relative risk of failure
for fistulae cannulated 14 days compared to 14 days  2.1 (P 
0.006; N  642).
ever, a large proportion of the 118 patients studied had
previous temporary catheters. Insertion of temporary
catheters is associated with a number of local complica-
tions [3] and their presence is subsequently associated creation diverge at the start and then again later in the
with a sevenfold increase in risk of infection compared study period. This suggests acute complications in the
with A-V fistulae [18]. The present and other recent stud- first one to two weeks after earlier cannulation and per-
ies show that the use of prior temporary catheters also haps a delayed effect related to cannulation trauma. This
is associated with shortening of subsequent A-V fistula hypothesis could be tested in an experimental A-V fistula
survival [9, 19]. model, which also would allow interventions aimed at
One may suppose that those A-V fistulae that are inhibiting such a pathological process. For example, a
sufficiently well developed to be cannulated within 14 days possible beneficial role of angiotensin converting enzyme
of creation would be those where the artery and vein are inhibiting medications has been suggested (abstract;
of a larger caliber or better quality. Therefore, it is all Young et al, J Am Soc Nephrol 12:307A, 2001) [20].
the more striking that these fistulae have a significantly These data suggest that A-V fistulae should be left to
worse long-term survival. The survival curves of fistulae mature for at least 14 days before first cannulation. Fur-
ther studies are required to allow more reliable selectionfor those cannulated before and later than 14 days after
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6. Berthoux F, Jones E, Gellert R, et al: Epidemiological data ofof those fistulae that are suitable for cannulation after
treated end-stage renal failure in the European Union (EU) during
14 days. Currently, this decision must rely on clinical judg- the year 1995: Report of the European Renal Association Registry
and the National Registries. Nephrol Dial Transplant 14:2332–2342,ment, perhaps supplemented by measurement of fistula
1999blood flow rate using color Doppler ultrasound [21].
7. Young EW, Goodkin DA, Mapes DL, et al: The Dialysis Out-
Furthermore, staff training and experience in A-V fistula comes and Practice Patterns Study (DOPPS): An international
hemodialysis study. Kidney Int 57(Suppl 74):S74–S81, 2000cannulation also may be an important pre-condition for
8. Klein JP, Moeschberger ML: Survival Analysis Techniques fora successful program in cannulating and maintaining A-V
Censored and Truncated Data. Springer, New York, 1997, p 417
fistulae. This study suggests that urgent placement of an 9. Pisoni RL, Young EW, Dykstra DM, et al: Vascular access use
in Europe and the United States: Results from the DOPPS. KidneyA-V fistula and cannulation after two weeks may be feas-
Int 61:305–316, 2002ible without an added risk of subsequent A-V fistula fail-
10. Miller A, Holzenbein TJ, Gottlieb MN, et al: Strategies to in-
ure for certain types of patients. This approach may avoid crease the use of autogenous arteriovenous fistula in end-stage
renal disease. Ann Vasc Surg 11:397–405, 1997the use of central venous catheters in these patients. Our
11. Allon M, Bailey R, Ballard R, et al: A multidisciplinary ap-data fail to substantiate the wisdom of an arbitrary one-
proach to hemodialysis access: Prospective evaluation. Kidney Int
month delay before cannulation of A-V fistulae. 53:473–479, 1998
12. Ascher E, Gade P, Hingorani A, et al: Changes in the practice
of angioaccess surgery: Impact of dialysis outcome and qualityACKNOWLEDGMENT
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